| Objective: To observe the clinical efficacy of the modified Danggui Niantong Decoction in the treatment of psoriasis vulgaris(moist toxin accumulation type).Methods: Seventy-six patients with psoriasis vulgaris(moist toxin accumulation type)meeting the standard were picked and stochastically divided to 38 cases each in treatment group and control group.The treatment group was treated with modified Danggui Niantong Decoction,while the control group was given Yinxie granules.Both groups were treated with Tacalcitol Unguent.The clinical efficacy judgment time were 4 weeks.The PASI scores,TCM syndrome scores,DLQI scores,adverse reactions were recorded and statistically analyzed in the beginning and the second and fourth weeks of the treatment process.Then the clinical efficacy and safety of the two groups were synthetically appraised.Results:1.The PASI,TCM syndrome,and DLQI scores of patients after 2 weeks were compared with those before treatment,and the scores after 4 weeks were also compared with those before treatment and after 2 weeks.The differences within and between groups(P<0.05)shows the two groups have both evident effects on reducing psoriasis area and severity,relieving TCM syndromes and improving the life qualities.And the treatment group has better efficacy.2.Total effective rate of the treatment group is 86.11%,higher than that of the control group(75%),showing the difference is statistically meaningful(P<0.05).Conclusion:1.The modified Danggui Niantong Decoction can effectively improve the symptoms of patients with psoriasis vulgaris(moist toxin accumulation type).2.The modified Danggui Niantong Decoction is secure and effective for psoriasis vulgaris(moist toxin accumulation type). |